Similarly, patients with lung cancer and T2DM had significantly higher mortality (HR=1.27, 95% CI: 1.07-1.50) than non-T2DM patients, irrespectively receiving insulin or metformin treatment (12). The gene discussed is INS; the disease is type 2 diabetes mellitus.